Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hematologic Diseases × Midazolam × Clear all

Sponsor

Conditions

Neoplasms 3 Melanoma 2 Lung Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Urothelial Cancer 1 Synovitis, Pigmented Villonodular 1 Solid Tumor 1 Skin Neoplasms 1 Rectal Neoplasms 1 Polyps 1 Patient Satisfaction 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Glioma 1 Diverticulosis, Colonic 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Carcinoma 1 Brain Neoplasms 1 Brain Diseases 1 Anxiety Disorders 1 Advanced Cancer 1

Interventions

Brentuximab Vedotin 10 fludarabine 7 Rituximab 6 Cyclophosphamide 6 fludarabine phosphate 5 Melphalan 5 ruxolitinib 4 ponatinib 4 Busulfan 4 Bortezomib 4 nilotinib 3 Whole-Body Irradiation 3 Vincristine 3 Prednisone 3 Lenalidomide 3 Imatinib Mesylate 3 Doxorubicin 3 Alemtuzumab 3 vosaroxin 2 Tacrolimus 2 Sugars 2 Stem Cell Transplantation 2 Mycophenolic Acid 2 Granulocyte Colony-Stimulating Factor 2 Etoposide 2 Dexamethasone 2 Calcium Dobesilate 2 Bendamustine Hydrochloride 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 sonidegib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡